13.10.2013gene13ab.ppt1 the pathogenesis of diseases from genetic and genomic point of view oliver...

60
13.10.2013 gene13ab.ppt 1 The Pathogenesis of The Pathogenesis of Diseases from Genetic Diseases from Genetic and Genomic Point of and Genomic Point of View View Oliver Oliver R R ácz and ácz and František Ništiar František Ništiar Institute of Pathological Institute of Pathological Physiology Physiology Medical School, Šafárik Medical School, Šafárik University University 2012/2013 2012/2013

Upload: carmella-stokes

Post on 18-Dec-2015

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 1

The Pathogenesis of Diseases from The Pathogenesis of Diseases from Genetic and Genomic Point of ViewGenetic and Genomic Point of View

Oliver Oliver RRácz and František Ništiarácz and František Ništiar

Institute of Pathological PhysiologyInstitute of Pathological Physiology

Medical School, Šafárik UniversityMedical School, Šafárik University

2012/20132012/2013

Page 2: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 2

26th june 2000 26th june 2000 is neither the beginning nor the end of is neither the beginning nor the end of

the waythe way 5 years before term (1990 - 2005) 5 years before term (1990 - 2005) The race is over, victory for Craig Venter.The race is over, victory for Craig Venter. The genome is mappedThe genome is mapped** - now what ? - now what ?

Not a discovery!Not a discovery! A very important technological result and A very important technological result and

competition is always useful.competition is always useful. all is based on Mendel‘s and Watson‘s & Crick‘s all is based on Mendel‘s and Watson‘s & Crick‘s

discoveries in XIXth XXth centurydiscoveries in XIXth XXth century

*3*109 letters

Page 3: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 3

Mendel, Watson, Crick & the medical Mendel, Watson, Crick & the medical geneticsgenetics of XIX of XIXthth – XX – XXthth century century

Mendel‘s laws are valid also todayMendel‘s laws are valid also today

Watson & Crick provided the material basis of Watson & Crick provided the material basis of these laws (central dogma of molecular biology)these laws (central dogma of molecular biology)

Mendel‘s laws in medicine can be applied to Mendel‘s laws in medicine can be applied to monogenic diseases – long list, relatively raremonogenic diseases – long list, relatively rare

What is the genetics of diabetes, hypertension, What is the genetics of diabetes, hypertension, coronary heart disease, Alzheimer disease ?coronary heart disease, Alzheimer disease ?

Page 4: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 4

White flowerWhite flower fromfrom red red parents ???parents ???

Page 5: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 5

Page 6: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 6

Quidditch ball for Harry Potter ?

Page 7: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 7

We discovered the secret of life, let’s have a beer!

Page 8: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 8

Page 9: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 9

The classicsThe classics

Mendel G: Versuche Mendel G: Versuche über Pflanzen-über Pflanzen-Hybriden. Verh. Naturfortsch. Verein Hybriden. Verh. Naturfortsch. Verein Brünn, 4, 1866, 3-47Brünn, 4, 1866, 3-47

Watson.JD, Crick FHC: Watson.JD, Crick FHC: Molecular Molecular structure of nucleic acids. structure of nucleic acids. Nature 171, 1953, 737-738Nature 171, 1953, 737-738

Page 10: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 10

CentralCentral dogma dogma of of molemolecculularar biolbiolooggyy ( (cca. cca. 1965)1965)

ReplicationTranscriptionTranslationTransformation

Page 11: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 11

Page 12: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 12

CentralCentral dogma dogma of of molemolecculularar biolbiolooggyy

Page 13: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 13

CentralCentral dogma dogma of of molemolecculularar biol biolooggyy? ? Epigenetics ? Role of RNA?Epigenetics ? Role of RNA?

•Regulation of transcription

•Transcription factors, etc.

•Methylation, acetylation…

•Regulation of RNA editing

•Alternative splicing

•Regulation of RNA transport

•Regulation of translation

•siRNA, tRNA modifications

•Postsynthetic modifications

Page 14: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 14

CentralCentral dogma dogma of of molemolecculularar biol biolooggyy

Page 15: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 15

CentralCentral dogma dogma of of molemolecculularar biolbiolooggyy ( (nownow)) – role of RNAs – role of RNAs

ReplicationTranscriptionTranslationTransformation

Page 16: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 16

It is a little more complicatedIt is a little more complicated

Page 17: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 17

We and our relativesWe and our relativesOrganismOrganism Genome sizeGenome size chromosomeschromosomes/ /

genesgenes

Homo sapiensHomo sapiens 3 000 000 0003 000 000 000 23/30 00023/30 000

Mus musculusMus musculus 2 600 000 0002 600 000 000 20/30 00020/30 000

D. MelanogasterD. Melanogaster 137 000 000137 000 000 4/13 0004/13 000

C. ElegansC. Elegans 97 000 00097 000 000 6/19 0006/19 000

S. CerevisiaeS. Cerevisiae 12 100 00012 100 000 18/6 00018/6 000

E. ColiE. Coli 4 600 0004 600 000 {1}3 200{1}3 200

HIV virusHIV virus 9 7009 700 99

A. ThalianaA. Thaliana 100 000 000100 000 000 ?/25 000?/25 000

Page 18: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 18

What is not What is not “genetic”“genetic” The number of human genes is as low as 30 000The number of human genes is as low as 30 000

the small worm C. elegans has 20 000 genesthe small worm C. elegans has 20 000 genes the mouse has as many genes as we, also with very similar the mouse has as many genes as we, also with very similar

functionfunction

The mystery is in complexity and networking: The mystery is in complexity and networking: 223000030000 >>>> 2 >>>> 220000 20000 (possible on/off states)(possible on/off states)

And a number of surprises around transcription And a number of surprises around transcription and translation (miRNA, tRNA modifications)and translation (miRNA, tRNA modifications)

It is mapped but do we understand it? It is mapped but do we understand it? GENETICS = HEREDITYGENETICS = HEREDITY GENOMICS = EVERYTHINGGENOMICS = EVERYTHING

Page 19: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 19

GGEENNESES A AND THE ENVIRONMENTND THE ENVIRONMENT

GENOME ENVIRONMENT

SEVERE MONOGENICDISEASES

LESS IMPORTANT MUTATIONS

GENETIC RISK

NEGATIVE ANDPOSITIVE

ENVIRONMENTAL FACTORS

physicalchemicalbiologicalnutritionlife style

Page 20: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 20

Genes and diseases in practical Genes and diseases in practical medicinemedicine

XIXth Century: symptom diagnosis

sugar in urine = diabetes

XXth Century: symptom etiopatogenesis diagnosis

autoimmune destruction of cells = dm Type 1

XXIst Century: symptom genes and environment

etiopatogenesis diagnosissusceptibility + overeating =

subtypes of dm Type 2

Page 21: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 21

New era of preventive medicineNew era of preventive medicine

Better understanding of disease Better understanding of disease pathogenesispathogenesis

Targeted, individualized preventionTargeted, individualized prevention Clear, unambiguous argumentsClear, unambiguous arguments Healthy genes Healthy genes healthy peoplehealthy people Genes sana in corpore sanoGenes sana in corpore sano

Page 22: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 22

MutationsMutations changes of genetic information changes of genetic information

THREE PRINCIPAL POSSIBILITIESTHREE PRINCIPAL POSSIBILITIES1.1. changes in genome not compatible with lifechanges in genome not compatible with life

2.2. development and diversitydevelopment and diversity

3.3. disease or disease or increased risk fo disease*increased risk fo disease*

THE BASIC DIFFERENCE FOR HEREDITY:THE BASIC DIFFERENCE FOR HEREDITY:– somatic and germ cell mutationssomatic and germ cell mutations

genome, chromosomal and genome, chromosomal and genegene mutations mutations

no genes for diseases! – sickle cell, Alzheimer, diabetes...

Page 23: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 23

Gene mutations and SNPs*Gene mutations and SNPs* Point mutations in exons Point mutations in exons

– silent, missense (AA change) and nonsense (stop)silent, missense (AA change) and nonsense (stop) Frameshift mutation in exons (1,2,4,5...)Frameshift mutation in exons (1,2,4,5...) Small deletion of triplets (3,6...)Small deletion of triplets (3,6...) Bigger deletions – transition to chromosomal aberrationsBigger deletions – transition to chromosomal aberrations Mutations in regulatory parts, intronsMutations in regulatory parts, introns, genes for r-tRNA, genes for r-tRNA Variability of repeated sequences - markersVariability of repeated sequences - markers Dynamic mutations – triple repeat mutationsDynamic mutations – triple repeat mutations

*SINGLE NUCLEOTID POLYMORPHISM

Page 24: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 24

Monogenic diseases with mendelian Monogenic diseases with mendelian inheritanceinheritance

Autosomal recessiveAutosomal recessive– sickle cell disease thalassemia and other sickle cell disease thalassemia and other

hemoglobinopathieshemoglobinopathies– cystic fibrosiscystic fibrosis– enzymopathies (inborn errors of metabolism)enzymopathies (inborn errors of metabolism)

Autosomal dominantAutosomal dominant– familiar hypercholesterolemiafamiliar hypercholesterolemia

X chromosome linked diseasesX chromosome linked diseases– hemophilia A, B; daltonismhemophilia A, B; daltonism

and von Willebrand disease, factor V Leiden, and von Willebrand disease, factor V Leiden, hereditary hemochromatosis...hereditary hemochromatosis...

Page 25: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 25

Sickle cell diseaseSickle cell disease Clinical description Clinical description 1910, Hb abnormality, 19401910, Hb abnormality, 1940 Pauling / Ingram - 1 AA change in Pauling / Ingram - 1 AA change in chain chain Point mutation – Glu Point mutation – Glu Val on 6th place (GAG/GTG)

Decreased solubility of Hb in low pO2

Rigid, deformed red cells in venous blood Thrombosis, decreased life span of Er, hemolysis,

icterus, anemia - HYPOXIA

Epidemiology: 8 % of black people in USA are heterozygotes; 1:400 homozygotes

5 – 20 % heterozygotes in some parts of Africa

Page 26: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 26

And the other haemoglobinopathies ?And the other haemoglobinopathies ?

Theoretical number – astronomicalTheoretical number – astronomical Known Known very rarevery rare Hb C = same point as Hb S but lysine, mild Hb C = same point as Hb S but lysine, mild

haemolysis. HbSC heterozygoteshaemolysis. HbSC heterozygotes Different types: labile, low and high oxygen affinity, Different types: labile, low and high oxygen affinity,

methemoglobin formation, etc.methemoglobin formation, etc. Why is sickle cell disease relative common?Why is sickle cell disease relative common? Plasmodia malariae do not like Hb S!Plasmodia malariae do not like Hb S! AA dies on malaria, SS on sickle cell diseaseAA dies on malaria, SS on sickle cell disease AS have relative advantage for survivalAS have relative advantage for survival

Page 27: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 27

Occurrence of Hb S in the worldOccurrence of Hb S in the world

Page 28: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 28

Page 29: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 29

The molecular structure of human HbThe molecular structure of human Hb

Page 30: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 30

Normal and sickled red cellsNormal and sickled red cells

Page 31: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 31

The pathogenesis of sickle cell diseaseThe pathogenesis of sickle cell disease

Page 32: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 32

Globin genesGlobin genes

16p - alfa family

11p - beta family

GA

Page 33: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 33

Globin genes - ontogenesisGlobin genes - ontogenesis

GA

Gower 1

Portland

Gower 2

Fetal

Page 34: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 34

Globin genes - adultGlobin genes - adult

GA

A = (95%)

A = (1%)

3 exons and 2 introns

Page 35: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 35

Globin genes – Globin genes – regularegulattion!ion!

GA

A = (95%)

A = (1%)

3 exons and 2 introns

LCR = locus control region with promoter and 2 enhancers before the cluster

LCR deletion – no gama/delta/beta chain synthesis

Page 36: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 36

ThalassemiasThalassemias Deletion of smaller or bigger parts of Deletion of smaller or bigger parts of or or gene gene

region region (or mutation in regulatory parts, nonsense mutation (or mutation in regulatory parts, nonsense mutation

and intron splicing mutations)and intron splicing mutations) deletions – back to embryonal Hb F if possibledeletions – back to embryonal Hb F if possible deletions – 2*2 = 4 genes!deletions – 2*2 = 4 genes! norm, healthynorm, healthy 1 deletion, clinically not manifest1 deletion, clinically not manifest 2 deletions, clinically mild/not manifest2 deletions, clinically mild/not manifest thalassemia Hb Bart = thalassemia Hb Bart = 44

no no hydrops fetalishydrops fetalis

Page 37: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 37

Alpha thalassemiasAlpha thalassemias

GA

2-krát

Page 38: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 38

Beta thalassemiaBeta thalassemia

GA

Page 39: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 39

Cystic fibrosisCystic fibrosis

Woe to that child which when kissed on the Woe to that child which when kissed on the forehead tastes salty. He is bewitched and soon forehead tastes salty. He is bewitched and soon must diemust die

Anders, 1938 – cystic fibrosis of pancreasAnders, 1938 – cystic fibrosis of pancreas Farber, 1945 - mukoviscidosisFarber, 1945 - mukoviscidosis SR 3 centres – BA, BB, KE (cca 60)SR 3 centres – BA, BB, KE (cca 60) 1/21/266 heterozygot heterozygoteses, 1/2, 1/2736, (1/676 marriages)736, (1/676 marriages) Increased NaCl is sweat, thick secrets of glands in Increased NaCl is sweat, thick secrets of glands in

bronchi, pancreas, GIT - organ failure, deathbronchi, pancreas, GIT - organ failure, death Disorder of reverse chloride Disorder of reverse chloride and water and water transporttransport

Page 40: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 40

Cystic fibrosis competitionCystic fibrosis competitionWillamson et al., London Willamson et al., London 1987 1987 - miss- miss

Lap-Chee Tsui a spol, Toronto, 1989 - hitLap-Chee Tsui a spol, Toronto, 1989 - hit

VVery different situation compared to Hb Sery different situation compared to Hb S– The faulty protein was not knownThe faulty protein was not known– The localization of the gene was unkownThe localization of the gene was unkown

Genetic linkage with an enzyme polymorphism - Genetic linkage with an enzyme polymorphism - chromosome 7 (classical genetics)chromosome 7 (classical genetics)

Further markers, narrowing down of the regionFurther markers, narrowing down of the region 4 clones, 1 complementary with cDNA4 clones, 1 complementary with cDNA** of a of a

protein from sweat glandprotein from sweat gland Localization and sequenation of the geneLocalization and sequenation of the gene

*cDNA = mirror of mRNA for a synthesized protein

Page 41: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 41

Cystic fibrosisCystic fibrosis

Different from haemoglobinopathies:Different from haemoglobinopathies:– No known protein involvedNo known protein involved– Unknown site for mutationUnknown site for mutation

Genetic linkage with an enzyme polymorphism Genetic linkage with an enzyme polymorphism located on ch. 7located on ch. 7

Further markers in the regionFurther markers in the region 4 clones, 1 is complementary to a sequence from 4 clones, 1 is complementary to a sequence from

sweat glandsweat gland the gene is found and sequencedthe gene is found and sequenced

Page 42: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 42

Cystic fibrosisCystic fibrosis

CFTR (cystic fibrosis conductance regulator gene)CFTR (cystic fibrosis conductance regulator gene) 1989, chromosome 7 - a big gene with 24 exons1989, chromosome 7 - a big gene with 24 exons Codes a big transmembrane protein - Cl channelCodes a big transmembrane protein - Cl channel More than More than 101000 mutations found in the gene00 mutations found in the gene

BUTBUT 60 % patients have a triplet deletion - omission a 60 % patients have a triplet deletion - omission a

Phe on 508th place of proteinPhe on 508th place of protein additional 15 % 8 other mutations (also in introns)additional 15 % 8 other mutations (also in introns)

Page 43: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 43

The structure of chloride transporter coded by The structure of chloride transporter coded by CFTR geneCFTR gene

Page 44: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 44

The structure of chloride transporter coded by The structure of chloride transporter coded by CFTR geneCFTR gene

Page 45: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 45

CCFTR proteinFTR protein

2 transmembrane domains (Cl transport)2 transmembrane domains (Cl transport) 2 nucleotide binding domains (for ATP)2 nucleotide binding domains (for ATP) Regulation domain RRegulation domain R REGULATION ALSO OF OTHER CHANNELS !!!REGULATION ALSO OF OTHER CHANNELS !!! Different functions in sweat and other glands !!!Different functions in sweat and other glands !!!

Page 46: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 46

CFTR is a chloride channelCFTR is a chloride channelBUTBUT

Its functions are tissue specificIts functions are tissue specific

Page 47: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 47

Sweat glands – salty sweatSweat glands – salty sweat

Cooperation with ENaC, NaCl in sweat low

No CFTR, salty sweat

Page 48: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 48

Other exocrine glandsOther exocrine glandsthick secretsthick secrets

Cooperation with ENaC, influences of water transport

(and ofj bicarbonate)

No CFTR, thick acid secrets

Page 49: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 49

How many How many cystic fibrcystic fibroses we haveoses we have? ? Typical monogenous disease (?)Typical monogenous disease (?) The number of known mutations in CFTR gene The number of known mutations in CFTR gene >>

13130000 6666 % % of patients have a deletion of aof patients have a deletion of a triplet triplet inin

1010thth ex exoonn = = deletion ofdeletion of Phe 508 Phe 508, the protein is , the protein is degraded in the endoplasmic reticulumdegraded in the endoplasmic reticulum

2020 otherother mut mutationsations (a (also inlso in intron intronss) – ) – otherother 15 % 15 % patientspatients

6 6 different classes of mutationsdifferent classes of mutations – – different cldifferent clinicinicalal symptoms of also withoutsymptoms of also without

MiMixedxed heterozygot heterozygotes es !!!!!!

Page 50: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 50

Cystic fibrosisCystic fibrosis

Norm: Norm: ATC TTT = Ileu PheATC TTT = Ileu Phe Deletion: Deletion: ATATC TTC TTT T ATT = Ileu, ATT = Ileu, deleteddeleted CTT CTT but lack ofbut lack of TTT TTT PrenatPrenataal diagnostil diagnosticscs – – direct?direct? IndirectIndirect – – something is wrong with the something is wrong with the

genegene NaCl NaCl in sweatin sweat > 60 mmol/l> 60 mmol/l

Page 51: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 51

Cystic fibrosisCystic fibrosis

GGeennee t thheraperapyy – in – insserertion of the gene with viraltion of the gene with viral vevecctortorss into airway into airway epitepithhelelial cells – not a real ial cells – not a real successsuccess

Treatment ofTreatment of infec infectionstions, , dilution of mucusdilution of mucus, , improvement of the digestionimprovement of the digestion

PhPhyyssiotiothheraperapyy PsychosociPsychosocialal carecare Lung tLung transplantransplantationation SURVISURVIVAVALL 1975 10 – 15 years, today > 401975 10 – 15 years, today > 40

Page 52: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 52

Mixed heterozygotesMixed heterozygotes

508/508508/508 508/other508/other Other/otherOther/other

NoNo 151151 117117 2525

%% 5252 4040 88

Panreas Panreas insuficiencyinsuficiency

99%99% 72%72% 36%36%

Pancreas okPancreas ok 1%1% 28%28% 64%64%

Age at dgAge at dg 1,8 y1,8 y 4,4 y4,4 y 8,4 y8,4 y

Page 53: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 53

Clinical manifestation Clinical manifestation (Spišák, Feketeová)(Spišák, Feketeová)

TYPICAL SPTsTYPICAL SPTs– Progressive bronchopulmonal Progressive bronchopulmonal

diseasedisease

– Nasal polypsNasal polyps

– Pancreas insufficiencyPancreas insufficiency

– Meconium ileusMeconium ileus

– Male infertilityMale infertility

– MalnutritionMalnutrition

– Growth retardationGrowth retardation

– Rectal prolapsRectal prolaps

ATYPICAL SPTsATYPICAL SPTs– IcterusIcterus

– Distal gut obstructionDistal gut obstruction

– Liver and bile tract Liver and bile tract malfunctionmalfunction

– PankreatitisPankreatitis

– Chronic rhinosinusitisChronic rhinosinusitis

– Diabetes mellitusDiabetes mellitus

Spišák B, Feketeová A: Cystická fibróza Pediatria 1, 2006,, 194-198

Page 54: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 54

Hemophilia AHemophilia A

Talmud Talmud Queen Victoria and her descendantsQueen Victoria and her descendants Family of the last Russian Czar Nicolaus Family of the last Russian Czar Nicolaus

((Alexandra - 4 daughters and one affected son)Alexandra - 4 daughters and one affected son) Absolute deficiency of factor VIIIAbsolute deficiency of factor VIII 1/10000 boys, one third are new mutations in their 1/10000 boys, one third are new mutations in their

ancestors (during meiosis)ancestors (during meiosis) High number of mutations, the most common High number of mutations, the most common

form is an form is an inversion inversion with 0 activity of factorwith 0 activity of factor

Page 55: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 55

HHemophilia Aemophilia A

Page 56: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 56

Structure of factor VIII and IX genes and proteins Structure of factor VIII and IX genes and proteins (with vWf)(with vWf)

F VIII F IX

Page 57: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 57

Other coagulopathiesOther coagulopathies

Haemophilia B - similar to AHaemophilia B - similar to A Haemophilia C - AR heredityHaemophilia C - AR heredity All other factors - very rareAll other factors - very rare Von Willebrand disease - AD; mild or Von Willebrand disease - AD; mild or

asymptomatic, heterogeneousasymptomatic, heterogeneous vW factor is a big protein with multiple function - vW factor is a big protein with multiple function -

stabilizes factor VIIIstabilizes factor VIII Bleeding when associated with other Bleeding when associated with other

circumstances (acetylsalicylic acid)circumstances (acetylsalicylic acid)

Page 58: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 58

An „upside down“ coagulopathyAn „upside down“ coagulopathy

Hereditary thrombophiliaHereditary thrombophilia Point mutation in factor V (Leiden)Point mutation in factor V (Leiden) The protein is The protein is resistant resistant to thrombolytic to thrombolytic

inactivation. inactivation. Part of common european heritage (2-7 %)Part of common european heritage (2-7 %) Elevated risk of venous thrombosis:Elevated risk of venous thrombosis: VV = 1; vV = 7; vVV = 1; vV = 7; vvv = 80; = 80; Manifestation in association with other Manifestation in association with other

circumstancescircumstances

Page 59: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 59

Disorder of color vision – daltonismDisorder of color vision – daltonism

Francis Dalton, Manchester, fyzik (1776-1844)Francis Dalton, Manchester, fyzik (1776-1844) Did not understand why he perceived the colors Did not understand why he perceived the colors

differently as other people and let his eyes conserved differently as other people and let his eyes conserved in formalinein formaline

4 4 phphotoreceptors (G-proteins, Guiness recored in otoreceptors (G-proteins, Guiness recored in sensisensittivity), vitamin Aivity), vitamin A

Genes for red and green opsins are on the X, 98 % Genes for red and green opsins are on the X, 98 % homolog, polymorphhomolog, polymorph

8 % white men (no selection pressure)8 % white men (no selection pressure) Gene analysis from DaltonGene analysis from Dalton’s’s retin retinaa – 1992 – 1992

Page 60: 13.10.2013gene13ab.ppt1 The Pathogenesis of Diseases from Genetic and Genomic Point of View Oliver Rácz and František Ništiar  Oliver Rácz and František

13.10.2013 gene13ab.ppt 60

Disroder of color visionDisroder of color vision